Financials
- Market Capitalization 51.75 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry 医薬品メーカー(一般)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
0.52
売上高対価格比率
513.45
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4126 | VBIO Valion Bio, Inc. - Common stock | 3.17 USD | +3.26% | +1881.25% | +890.63% | +164.17% | 70.34 M USD | ||
| 4178 | EXOZ eXoZymes Inc. - Common Stock | 6.79 USD | +4.46% | +2.26% | +38.85% | -30.00% | 63.02 M USD | ||
| 4290 | SCLX Scilex Holding Company - Common Stock | 5.33 USD | -1.30% | -4.99% | -18.63% | -34.44% | 45.27 M USD | ||
| 4372 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.85 USD | -1.16% | +13.33% | +8.97% | -39.29% | 35.72 M USD |